HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

  • J9218

    Leuprolide acetate, per 1 mg

  • J9219

    Leuprolide acetate implant, 65 mg

  • J9220

    Injection, indigotindisulfonate sodium, 1 mg

  • J9223

    Injection, lurbinectedin, 0.1 mg

  • J9225

    Histrelin implant (vantas), 50 mg

  • J9226

    Histrelin implant (supprelin la), 50 mg

  • J9227

    Injection, isatuximab-irfc, 10 mg

  • J9228

    Injection, ipilimumab, 1 mg

  • J9229

    Injection, inotuzumab ozogamicin, 0.1 mg

  • J9230

    Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg

  • J9245

    Injection, melphalan hydrochloride, not otherwise specified, 50 mg

  • J9246

    Injection, melphalan (evomela), 1 mg

  • J9247

    Injection, melphalan flufenamide, 1mg

  • J9248

    Injection, melphalan (hepzato), 1 mg

  • J9249

    Injection, melphalan (apotex), 1 mg

  • J9250

    Methotrexate sodium, 5 mg

  • J9255

    Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg

  • J9256

    Injection, nipocalimab-aahu, 3 mg

  • J9258

    Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg

  • J9259

    Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg

  • J9260

    Injection, methotrexate sodium, 50 mg

  • J9261

    Injection, nelarabine, 50 mg

  • J9262

    Injection, omacetaxine mepesuccinate, 0.01 mg

  • J9263

    Injection, oxaliplatin, 0.5 mg

  • J9264

    Injection, paclitaxel protein-bound particles, 1 mg

  • J9265

    Injection, paclitaxel, 30 mg

  • J9266

    Injection, pegaspargase, per single dose vial

  • J9267

    Injection, paclitaxel, 1 mg

  • J9268

    Injection, pentostatin, 10 mg

  • J9269

    Injection, tagraxofusp-erzs, 10 micrograms

  • J9270

    Injection, plicamycin, 2.5 mg

  • J9271

    Injection, pembrolizumab, 1 mg

  • J9272

    Injection, dostarlimab-gxly, 10 mg

  • J9273

    Injection, tisotumab vedotin-tftv, 1 mg

  • J9274

    Injection, tebentafusp-tebn, 1 microgram

  • J9275

    Injection, cosibelimab-ipdl, 2 mg

  • J9276

    Injection, zanidatamab-hrii, 2 mg

  • J9277

    Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph

  • J9278

    Injection, carboplatin (avyxa), 1 mg

  • J9280

    Injection, mitomycin, 5 mg

  • J9281

    Mitomycin pyelocalyceal instillation, 1 mg

  • J9282

    Mitomycin, intravesical instillation, 1 mg

  • J9285

    Injection, olaratumab, 10 mg

  • J9286

    Injection, glofitamab-gxbm, 2.5 mg

  • J9289

    Injection, nivolumab, 2 mg and hyaluronidase-nvhy

  • J9292

    Injection, pemetrexed dipotassium, 10 mg

  • J9293

    Injection, mitoxantrone hydrochloride, per 5 mg

  • J9294

    Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg

  • J9295

    Injection, necitumumab, 1 mg

  • J9296

    Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.